A unique investment opportunity
Executive summary
World-class pharmaceutical complex
Vaudreuil-Dorion’s former Hoffmann-La Roche Complex, strategically placed where the two highways from Toronto and from Ottawa merge on their way to Montreal. Within 20 minutes of Montreal Trudeau International Airport.
- 90,000 sq. ft of secure warehouse processing activities
- Full perimeter security and gate controlled entry
- Large scale growing operation of 90,000 sq. ft
- Educational hub with lobby, meeting rooms, office space, cafeteria and 158-seat auditorium
- Scalable mechanical capacity and high density water delivery
- 70 acres site provides for additional purpose-built structures
- 4-story lab tower of 10,000 sq. ft per floor for research and testing labs
- 100% interlinked through underground passageways
- 5 stories of 12,000 sq. ft dedicated for craft growing
We form partnerships with industry leaders
McGill University has designated C3 as one of the institution’s primary locations of its Center for Cannabis Research.
Meet our team
Jonathan
Morrison
President
Marc Lemaire
CPA, CA, IAS. A
Finance
George
Lathouras
Real Estate
Francois Dionne
St-Arneault Marketing
Jean-Robert
Pronovost
Investments
Alyssa Bleser
LL. B.
Legal
Steve
Naraine
Science & Compliance
Sebastien
Harvey
Investor Relations
News
Troy Media
18.06.2019
"Companies will no doubt partner up, sharing research and development and distribution strategies. The C3 facility in Montreal, the Global Cannabis Innovation Centre, involves McGill University and offers a good example of that." See full story
The Globe and Mail
16.06.2019
"To cope with the ironclad rules requiring separate facilities, companies will collaborate more, which will lead to partnerships and situations where they co-share R&D agendas and distribution strategies. The C3 Global Cannabis Innovation Centre in Montreal that includes McGill University is a good example." See full story
CBC News
14.06.2019
This facility will host close do thirty cannabis companies. See full story
TVA
14.06.2019
«McGill vient essentiellement créer une faculté de cannabis à l'intérieur du complexe, qu'on vient associer avec les entreprises qui viennent opérer ici et qui veulent créer des produits différenciés», explique le président du Centre mondial d’innovation du cannabis, Jonathan Morrison. See full story
Cannabis Growth Opportunity Corporation
08.05.2019
Jamie Blundell, President and Chief Operating Officer of CGOC commented, "We are excited to be a part of the C3 journey, as they foster the development of early stage cannabis companies. They have a solid team in place, and a unique business strategy which we are very supportive of." See full story
La Presse
26.04.2019
L'Université McGill développe avec un groupe d'entrepreneurs québécois un concept d'« incubateur d'idées » consacré à la recherche sur le cannabis, qui pourrait donner une seconde vie à un gigantesque complexe pharmaceutique abandonné en 1980 par la société suisse Hoffmann-La Roche. See full story
Contact us
